Drug:
Reaction: DECREASED APPETITE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26947984 |
US |
1 | |
Cough, Decreased appetite, Nausea, Product deposit, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NERANDOMILAST, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FUROSEMIDE, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RITUXIMAB, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, FINASTERIDE, GABAPENTIN, LATANOPROST, ERGOCALCIFEROL, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 102 | 26948004 |
US |
74 | 2 |
Feeling cold, Brain fog, Tremor, Dizziness postural, Anxiety, Blood pressure fluctuation, Weight decreased, Blood pressure decreased, Abdominal discomfort, Decreased appetite, Feeling abnormal, Blood pressure increased, Dizziness, Heart rate increased, Constipation, Headache, Vertigo, Fatigue, Nausea, Therapy interrupted, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, EVOLOCUMAB, |
||||
| 103 | 26948079 |
US |
2 | |
Disturbance in attention, Decreased appetite, Headache, Nausea, Diarrhoea, Dizziness, Insomnia, Malaise, Hot flush, Heart rate increased, Asthenia, |
||||
ABALOPARATIDE, |
||||
| 104 | 26948106 |
US |
2 | |
Cold sweat, Decreased appetite, Blood calcium increased, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALBUTEROL SULFATE, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM OXIDE, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, |
||||
| 105 | 26948185 |
JP |
44 | 2 |
Dyspnoea exertional, Decreased appetite, Pulmonary hypertension, |
||||
SELEXIPAG, MACITENTAN, EPOPROSTENOL, EPOPROSTENOL, EPOPROSTENOL, EPOPROSTENOL, RIOCIGUAT, |
||||
| 106 | 26951441 |
85 | 2 | |
Weight decreased, Fall, Asthenia, Gait disturbance, Decreased appetite, |
||||
TIRZEPATIDE, |
||||
| 107 | 26952259 |
87 | 2 | |
Renal injury, Neurotoxicity, Hepatotoxicity, Decreased appetite, Hypotension, Dialysis, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, CEFEPIME HYDROCHLORIDE, CEFEPIME, RIFAMPIN, |
||||
| 108 | 26934540 |
BR |
63 | 2 |
Syncope, Seizure, Urticaria, Nail injury, Hypersensitivity, Skin discolouration, Asthenia, Decreased appetite, Tooth infection, Acne, Angular cheilitis, Nausea, Dyspepsia, Stomatitis, Off label use, |
||||
PANITUMUMAB, PANITUMUMAB, EMPAGLIFLOZIN, ATENOLOL, OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 109 | 26934562 |
US |
66 | 2 |
Feeling abnormal, Decreased appetite, Headache, Fatigue, Nausea, |
||||
ORFORGLIPRON, ORFORGLIPRON, |
||||
| 110 | 26934738 |
US |
72 | 2 |
Urticaria, Skin burning sensation, Malaise, Palpitations, Disorientation, Hypertension, Infusion related reaction, Urticaria, Tremor, Decreased appetite, Nausea, Anaphylactoid reaction, Flushing, |
||||
MONTELUKAST SODIUM, PANTOPRAZOLE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 111 | 26934755 |
US |
2 | |
Dysphagia, Weight decreased, Decreased appetite, Diarrhoea, Fatigue, Asthenia, Hypotonia, Depression, Hypoaesthesia, Pain, Dyspnoea, Cough, Oropharyngeal pain, Pulmonary pain, Oesophageal hypomotility, Fall, Nasopharyngitis, Chest pain, Lactose intolerance, Product dose omission issue, |
||||
OSIMERTINIB, |
||||
| 112 | 26934768 |
EU |
47 | 1 |
Erectile dysfunction, Accidental overdose, Drug delivery system issue, Paraesthesia, Product quality issue, Decreased appetite, |
||||
| 113 | 26934901 |
CA |
44 | 2 |
Type 2 diabetes mellitus, Folliculitis, Peripheral venous disease, Obesity, Diarrhoea, Depression, Osteoarthritis, Exposure during pregnancy, Abdominal pain upper, Live birth, Impaired healing, Off label use, Sciatica, Lip dry, Glossodynia, Weight increased, Fibromyalgia, Joint swelling, Gastrooesophageal reflux disease, Discomfort, Dizziness, Alopecia, Nasopharyngitis, Paraesthesia, Night sweats, Vomiting, Lower respiratory tract infection, C-reactive protein increased, Delirium, Asthenia, Decreased appetite, Peripheral swelling, Epilepsy, Synovitis, Pregnancy, Urticaria, Intentional product use issue, Blepharospasm, Hypocholesterolaemia, Drug ineffective, Nail disorder, Product quality issue, Musculoskeletal pain, Pericarditis, Muscle injury, Bursitis, Infusion related reaction, Facet joint syndrome, Hepatic enzyme increased, Stomatitis, Injury, Dry mouth, Contraindicated product administered, Systemic lupus erythematosus, No adverse event, Condition aggravated, Drug hypersensitivity, Pemphigus, Maternal exposure timing unspecified, Memory impairment, X-ray abnormal, Blood cholesterol increased, Drug intolerance, Hand deformity, Arthralgia, Wheezing, Adverse drug reaction, Breast cancer stage III, Confusional state, Hypoaesthesia, Rash, Blister, Prescribed overdose, Joint range of motion decreased, Taste disorder, Anti-cyclic citrullinated peptide antibody positive, Adverse event, General physical health deterioration, Product use in unapproved indication, Wound infection, Psoriatic arthropathy, Abdominal discomfort, Abdominal pain, Sinusitis, Irritable bowel syndrome, Liver injury, Duodenal ulcer perforation, Helicobacter infection, Hypertension, Mobility decreased, Arthropathy, Inflammation, Migraine, Pain, Muscle spasms, Swelling, Wound, Lung disorder, Normal newborn, Hypercholesterolaemia, Headache, Fatigue, Maternal exposure during pregnancy, Malaise, Rheumatoid arthritis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VEDOLIZUMAB, CHLORHEXIDINE GLUCONATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, LAMOTRIGINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DESOXIMETASONE, TRAMADOL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 114 | 26935026 |
CN |
56 | 1 |
Anaemia, Pneumonia, Hypokalaemia, Arrhythmia, Hypokalaemia, Hypokalaemia, Deep vein thrombosis, Ascites, Anaemia, Hypocalcaemia, Anaemia, Anaemia, Weight decreased, Anaemia, Hypocalcaemia, Decreased appetite, Hypocalcaemia, Hypocalcaemia, Supraventricular tachycardia, Anaemia, Platelet count decreased, Hypocalcaemia, White blood cell count decreased, Hypocalcaemia, Neutrophil count decreased, Anaemia, Decreased appetite, Sinus tachycardia, Anaemia, Pyrexia, Hypocalcaemia, Insomnia, Hypocalcaemia, Platelet count decreased, Hypoproteinaemia, Infection, Anaemia, Hypocalcaemia, Platelet count decreased, White blood cell count decreased, Anaemia, Hypocalcaemia, Platelet count decreased, Hypocalcaemia, Hypersensitivity, Anaemia, Anaemia, Hypocalcaemia, Constipation, Anaemia, Platelet count decreased, Hypocalcaemia, Oedema peripheral, Platelet count decreased, Nausea, Vomiting, Anaemia, Hypocalcaemia, Platelet count decreased, Constipation, Hypocalcaemia, Pelvic fluid collection, Diarrhoea, Dysuria, Hypocalcaemia, |
||||
SOTORASIB, SOTORASIB, |
||||
| 115 | 26935037 |
US |
2 | |
Psoriasis, Headache, Decreased appetite, Memory impairment, Pain, Loss of personal independence in daily activities, |
||||
APREMILAST, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, CELECOXIB, GABAPENTIN, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, METHOTREXATE, METHOTREXATE SODIUM, TIZANIDINE, |
||||
| 116 | 26935064 |
US |
81 | 2 |
Decreased appetite, Nausea, |
||||
LENALIDOMIDE, |
||||
| 117 | 26935146 |
88 | ||
Sleep apnoea syndrome, Decreased appetite, Dizziness, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 118 | 26935255 |
US |
54 | 2 |
Illness, Decreased appetite, Nausea, |
||||
| 119 | 26935385 |
US |
56 | 1 |
Abdominal distension, Diarrhoea, Decreased appetite, |
||||
| 120 | 26935397 |
1 | ||
Decreased appetite, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 121 | 26935417 |
JP |
81 | 1 |
Cerebral infarction, Immunodeficiency, Subarachnoid haemorrhage, Dyspnoea, Productive cough, Malaise, Decreased appetite, Product use issue, |
||||
AVACOPAN, AVACOPAN, |
||||
| 122 | 26935666 |
JP |
57 | |
Death, Interstitial lung disease, Nausea, Decreased appetite, Diarrhoea, Constipation, Therapy non-responder, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 123 | 26935703 |
US |
61 | 2 |
Metastases to central nervous system, Breast cancer, Malignant neoplasm progression, Pneumonia, Confusional state, Metastases to meninges, Hypercalcaemia, Neuropathy peripheral, Carcinoembryonic antigen increased, Mitral valve thickening, Tricuspid valve incompetence, General physical health deterioration, Impaired work ability, Metastases to liver, Metastases to bone, Metastases to lung, Metastases to lymph nodes, Fatigue, Decreased appetite, Hepatic enzyme increased, Oedema peripheral, Weight decreased, Blood cholesterol increased, Asthenia, Lethargy, Feeling cold, Hilar lymphadenopathy, Drug intolerance, Dry skin, Oesophagitis, Radiation associated pain, Constipation, Taste disorder, Haemorrhoidal haemorrhage, Pollakiuria, Pain, Palpitations, Depression, Cough, Pyrexia, Incontinence, Aphasia, Crying, Anhedonia, Transaminases increased, Spinal pain, Stomatitis, Hot flush, Dyspepsia, Dizziness, Insomnia, Alopecia, Burning sensation, Diplopia, Hepatomegaly, Cholelithiasis, Pleural effusion, Lymphadenopathy mediastinal, Bone lesion, Vitamin D decreased, Monocyte count decreased, Blood chloride decreased, Blood urea decreased, Red blood cell count decreased, Alanine aminotransferase increased, Haematocrit decreased, Haemoglobin decreased, Blood albumin decreased, Mean cell haemoglobin decreased, Protein total decreased, Blood creatinine decreased, Blood sodium decreased, Blood calcium decreased, Lymphocyte count decreased, Lymphocyte count increased, Red cell distribution width increased, Carbohydrate antigen 15-3 increased, Blood calcium increased, Mean cell haemoglobin increased, Blood cholesterol increased, Mean cell volume increased, Blood triglycerides increased, Glycosylated haemoglobin increased, Low density lipoprotein increased, Non-high-density lipoprotein cholesterol increased, White blood cell count increased, Blood glucose increased, Blood alkaline phosphatase increased, Aspartate aminotransferase increased, Carbohydrate antigen 27.29 increased, Monocyte count increased, Platelet count increased, Mean cell haemoglobin concentration increased, Blood bilirubin increased, Neutrophil count increased, Prothrombin time prolonged, Urobilinogen urine increased, Protein urine present, Lung infiltration, Aortic valve sclerosis, Mitral valve calcification, Skin exfoliation, |
||||
EVEROLIMUS, LETROZOLE, LETROZOLE TABLETS, FAMOTIDINE, FULVESTRANT, FULVESTRANT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ALPRAZOLAM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ATENOLOL, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, EXEMESTANE, DENOSUMAB, PALBOCICLIB, ALPRAZOLAM, ALPRAZOLAM, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, ESCITALOPRAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, GADOTERATE MEGLUMINE, GADOTERATE MEGLUMINE, FOLIC ACID, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MORPHINE SULFATE, FERROUS SULFATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 124 | 26935767 |
CA |
43 | 2 |
C-reactive protein, Lip dry, Therapeutic product effect incomplete, Liver injury, Drug hypersensitivity, Adverse drug reaction, Normal newborn, Joint swelling, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hypercholesterolaemia, Exposure during pregnancy, Glossodynia, Duodenal ulcer perforation, Systemic lupus erythematosus, Confusional state, Contraindicated product administered, Oedema, General physical health deterioration, Blister, Musculoskeletal stiffness, Pericarditis, Hip arthroplasty, Anxiety, Deep vein thrombosis postoperative, Joint range of motion decreased, Pregnancy, Malaise, Chest pain, Abdominal discomfort, Hepatic enzyme increased, Decreased appetite, Nausea, Arthralgia, Hypoaesthesia, Fibromyalgia, Sleep disorder due to general medical condition, insomnia type, Red blood cell sedimentation rate increased, Rheumatic fever, Injury, Pain, Pain in extremity, Paraesthesia, Helicobacter infection, Type 2 diabetes mellitus, Visual impairment, Arthropathy, Gastrointestinal disorder, Infusion related reaction, Osteoarthritis, Retinitis, Irritable bowel syndrome, Pemphigus, Insomnia, Knee arthroplasty, Inflammation, Headache, Fatigue, Autoimmune disorder, Maternal exposure during pregnancy, Intentional product misuse, Oedema peripheral, Wound, Asthma, Drug intolerance, Infection, Rheumatoid factor positive, Asthenia, Discomfort, Treatment failure, Grip strength decreased, Intentional product use issue, C-reactive protein increased, Contusion, Diarrhoea, Arthritis, Rheumatoid arthritis, Rash, Hypertension, Blood cholesterol increased, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB CITRATE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB, VITAMIN C, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, APREMILAST, APREMILAST, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, APREMILAST, APREMILAST, APREMILAST, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, ABATACEPT, ABATACEPT, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ERENUMAB-AOOE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, ERGOCALCIFEROL, LISINOPRIL, CAFFEINE CITRATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 125 | 26935797 |
CN |
76 | 1 |
Upper gastrointestinal haemorrhage, Conjunctival pallor, Diverticulum intestinal, Palpitations, Atrioventricular block, Dry mouth, Listless, Nausea, Faeces soft, Intestinal obstruction, Neuropathy peripheral, Discomfort, Throat lesion, Haematemesis, Asthenia, Gastric ulcer, Gastric ulcer haemorrhage, Dizziness, Hyperhidrosis, Deep vein thrombosis, Arrhythmia, Renal impairment, Pyrexia, Pain, Decreased appetite, Anaemia, Abdominal tenderness, Fatigue, Gastric haemorrhage, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 126 | 26935968 |
US |
||
Decreased appetite, Weight decreased, Feeling abnormal, Hyperhidrosis, Blood glucose decreased, Tremor, |
||||
GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, |
||||
| 127 | 26936030 |
43 | 2 | |
Brain oedema, Starvation, Anxiety, Decreased appetite, Nervous system disorder, Immune system disorder, |
||||
USTEKINUMAB, |
||||
| 128 | 26936083 |
US |
2 | |
Diarrhoea, Decreased appetite, |
||||
ABEMACICLIB, |
||||
| 129 | 26936344 |
US |
67 | 2 |
Decreased appetite, Odynophagia, Dysphagia, Vomiting, Weight decreased, |
||||
DUPILUMAB, |
||||
| 130 | 26936400 |
US |
70 | 1 |
Shock, Off label use, Product dose omission issue, Weight decreased, Fatigue, Dizziness, Decreased appetite, Nausea, |
||||
MITOTANE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 131 | 26936479 |
JP |
23 | 2 |
Epilepsy, Weight decreased, Prescribed underdose, Off label use, Decreased appetite, Diarrhoea, Somnolence, |
||||
VALPROATE SODIUM, LACOSAMIDE, PERAMPANEL, PERAMPANEL, PERAMPANEL, PERAMPANEL, PERAMPANEL, PERAMPANEL, |
||||
| 132 | 26936533 |
CN |
42 | 2 |
Nausea, Vomiting, Decreased appetite, Hypophagia, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 133 | 26936977 |
US |
2 | |
Seizure, Urine odour abnormal, Lip dry, Feeling jittery, Pollakiuria, Dry mouth, Decreased appetite, Weight decreased, Anxiety, Intentional product misuse, Incorrect product administration duration, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, MODAFINIL, |
||||
| 134 | 26937001 |
US |
1 | |
Cataract, Gastroenteritis viral, Product dose omission issue, White blood cell count decreased, Decreased appetite, Sinusitis, Ocular hyperaemia, Anxiety, Depression, |
||||
ACALABRUTINIB, ACALABRUTINIB, |
||||
| 135 | 26937058 |
CO |
2 | |
Angina unstable, Accident, Fall, Limb injury, Pharyngeal disorder, Spinal disorder, Insomnia, Decreased appetite, Headache, Pain in extremity, Mobility decreased, Ear disorder, Thyroid disorder, |
||||
DENOSUMAB, |
||||
| 136 | 26937350 |
US |
67 | 1 |
Acute kidney injury, Toxicity to various agents, Lactic acidosis, Decreased appetite, Nausea, Vomiting, Drug interaction, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LISINOPRIL, |
||||
| 137 | 26937462 |
US |
58 | |
Full blood count decreased, Anaemia, Decreased appetite, Insomnia, Wrong technique in product usage process, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 138 | 26937623 |
US |
1 | |
Decreased appetite, Thirst decreased, Weight decreased, Administration site extravasation, Incorrect dose administered, |
||||
ETEPLIRSEN, ETEPLIRSEN, |
||||
| 139 | 26937973 |
CA |
69 | 2 |
Blood pressure increased, Decreased appetite, Dysgeusia, Fatigue, Headache, Peripheral swelling, |
||||
TOCILIZUMAB-AAZG, |
||||
| 140 | 26937984 |
US |
81 | 2 |
Dehydration, Diarrhoea, Electrolyte imbalance, Decreased appetite, Hallucination, Diarrhoea haemorrhagic, Asthenia, Pallor, Weight decreased, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 141 | 26938105 |
CN |
||
Leukopenia, Neutropenia, Thrombocytopenia, Anaemia, Decreased appetite, Fatigue, Hypertension, Palmar-plantar erythrodysaesthesia syndrome, Proteinuria, Neuropathy peripheral, Transaminases increased, Mouth ulceration, Stomatitis, Abdominal pain, Diarrhoea, Hyperbilirubinaemia, Blood lactate dehydrogenase increased, Blood alkaline phosphatase increased, Gamma-glutamyltransferase increased, Hypoproteinaemia, Dysphagia, Dysphonia, Hypothyroidism, Hyperthyroidism, Rash, Hepatitis, Pruritus, Pneumonia, Infusion related reaction, Nephritis, |
||||
ATEZOLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), NIVOLUMAB, |
||||
| 142 | 26938265 |
CO |
1 | |
Abdominal pain upper, Diarrhoea, Decreased appetite, Blood glucose increased, Oral disorder, Oropharyngeal pain, Immunosuppressant drug level increased, |
||||
TACROLIMUS, TACROLIMUS, |
||||
| 143 | 26938352 |
EU |
38 | 2 |
Breast abscess, Confusional state, Erythema, Bacteriuria, Bradycardia, Urinary tract infection, Urinary tract infection, Fall, Irritability, Amenorrhoea, Burning sensation, Disturbance in attention, Psychomotor retardation, Aphasia, Groin pain, Drug abuse, Decreased appetite, Weight decreased, Traumatic haematoma, |
||||
ALEMTUZUMAB, METHYLPREDNISOLONE, ACYCLOVIR, VALPROATE SODIUM, ALPRAZOLAM, PREGABALIN, ALPRAZOLAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 144 | 26938453 |
EU |
88 | 2 |
Pneumonia, Decreased appetite, Haemorrhage intracranial, Thrombocytopenia, |
||||
APIXABAN, APIXABAN, APIXABAN, APIXABAN, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BELANTAMAB MAFODOTIN, BELANTAMAB MAFODOTIN, BELANTAMAB MAFODOTIN, BELANTAMAB MAFODOTIN, |
||||
| 145 | 26938661 |
GB |
37 | 2 |
Weight decreased, Malnutrition, Dehydration, Blood pressure decreased, Blood glucose decreased, Decreased appetite, Urinary tract infection, Eating disorder, Renal injury, Cholecystitis, Alopecia, Body dysmorphic disorder, Drug abuse, Impaired gastric emptying, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 146 | 26938815 |
US |
87 | 2 |
Taste disorder, Decreased appetite, Fatigue, Diarrhoea, Nausea, |
||||
NIVOLUMAB, CABOZANTINIB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 147 | 26938881 |
US |
30 | 2 |
Oedema peripheral, Pain, Sensitive skin, Dizziness, Nausea, Fatigue, Gastric pH decreased, Decreased appetite, Loss of personal independence in daily activities, Mobility decreased, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 148 | 26938923 |
GB |
43 | 2 |
Immune system disorder, Nervous system disorder, Brain oedema, Anxiety, Starvation, Decreased appetite, |
||||
USTEKINUMAB, |
||||
| 149 | 26939080 |
US |
57 | 2 |
Arthropod bite, Decreased appetite, Nausea, Dizziness, |
||||
ABALOPARATIDE, VITAMIN C, ERYTHROMYCIN, |
||||
| 150 | 26939118 |
US |
2 | |
Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 151 | 26939138 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 152 | 26939189 |
US |
2 | |
Cold sweat, Feeling hot, Decreased appetite, Headache, Nausea, |
||||
ABALOPARATIDE, |
||||
| 153 | 26939228 |
US |
2 | |
Heart rate irregular, Dizziness, Heart rate increased, Decreased appetite, |
||||
ABALOPARATIDE, MAGNESIUM, BIOTIN, CALCIUM, FISH OIL, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 154 | 26939286 |
US |
2 | |
Adverse drug reaction, Decreased appetite, Blood calcium increased, Nausea, |
||||
ABALOPARATIDE, |
||||
| 155 | 26939336 |
US |
79 | 2 |
Flushing, Body temperature increased, Myalgia, Endocrine disorder, Haemoglobin decreased, Blood test abnormal, Decreased appetite, Confusional state, Headache, Palpitations, Hypercalcaemia, Bone pain, |
||||
ABALOPARATIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 156 | 26939400 |
US |
1 | |
Decreased appetite, Heart rate increased, Injection site pain, Headache, Product administration error, Suspected product contamination, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 157 | 26939422 |
US |
2 | |
Decreased appetite, Weight decreased, Nausea, Headache, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 158 | 26939495 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 159 | 26939508 |
US |
2 | |
Spinal operation, Decreased appetite, Diarrhoea, Abdominal pain upper, Nausea, |
||||
ABALOPARATIDE, |
||||
| 160 | 26939533 |
US |
64 | 2 |
Food aversion, Decreased appetite, Circumstance or information capable of leading to medication error, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 161 | 26939560 |
US |
1 | |
Decreased appetite, Pain, |
||||
ABALOPARATIDE, |
||||
| 162 | 26939695 |
US |
2 | |
Sciatica, Injection site pain, Urine analysis abnormal, Arthralgia, Abdominal pain upper, Headache, Decreased appetite, Needle issue, Product use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 163 | 26939781 |
US |
2 | |
Onychoclasis, Decreased appetite, Fatigue, |
||||
ABALOPARATIDE, CARVEDILOL, AMLODIPINE BESYLATE, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METHYLPREDNISOLONE, |
||||
| 164 | 26939856 |
US |
2 | |
Weight decreased, Decreased appetite, |
||||
ABALOPARATIDE, |
||||
| 165 | 26939868 |
US |
2 | |
Decreased appetite, Taste disorder, |
||||
ABALOPARATIDE, |
||||
| 166 | 26943070 |
75 | 2 | |
Decreased appetite, |
||||
PIRFENIDONE, |
||||
| 167 | 26943359 |
2 | ||
Malnutrition, Decreased appetite, Asthenia, Weight increased, |
||||
SOTATERCEPT-CSRK, |
||||
| 168 | 26943758 |
2 | ||
Malnutrition, Decreased appetite, Asthenia, Weight decreased, |
||||
MACITENTAN, SOTATERCEPT-CSRK, |
||||
| 169 | 26931298 |
US |
2 | |
Decreased appetite, Nausea, |
||||
TIRZEPATIDE, |
||||
| 170 | 26931541 |
US |
||
Fatigue, Headache, Palpitations, Decreased appetite, Hypercalcaemia, |
||||
PALOPEGTERIPARATIDE, |
||||
| 171 | 26931673 |
US |
49 | 1 |
Decreased appetite, Injection site mass, |
||||
| 172 | 26931712 |
58 | 2 | |
Primary hypoparathyroidism, COVID-19, Decreased appetite, |
||||
TIRZEPATIDE, |
||||
| 173 | 26931809 |
US |
9 | 2 |
Hallucination, Decreased appetite, Off label use, Sleep terror, Behaviour disorder, Fear, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
| 174 | 26931864 |
BR |
64 | 2 |
Asthenia, Dizziness, Hypokalaemia, Hyponatraemia, Presyncope, Vomiting, Nausea, Malaise, Decreased appetite, |
||||
BUPRENORPHINE, BUPRENORPHINE, INDAPAMIDE, ROSUVASTATIN CALCIUM, DENOSUMAB, |
||||
| 175 | 26931948 |
US |
59 | |
Decreased appetite, Pain, Dizziness, Feeling abnormal, Tension, Back pain, Anxiety, Nausea, |
||||
PALTUSOTINE, |
||||
| 176 | 26932007 |
US |
27 | |
Back pain, Arthralgia, Decreased appetite, |
||||
PALTUSOTINE, PALTUSOTINE, |
||||
| 177 | 26932171 |
US |
66 | 2 |
Malaise, Weight decreased, Headache, Decreased appetite, Feeling abnormal, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, |
||||
| 178 | 26932207 |
JP |
83 | 2 |
Cholangitis, Decreased appetite, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, MONTELUKAST, MAGNESIUM OXIDE, LANSOPRAZOLE, ROSUVASTATIN, SACUBITRIL AND VALSARTAN, |
||||
| 179 | 26932487 |
US |
7 | 1 |
Hiatus hernia, Vomiting, Throat irritation, Gastrooesophageal reflux disease, Condition aggravated, Gastroenteritis, Diarrhoea, Decreased appetite, Injection site pain, Injection site mass, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 180 | 26932720 |
EU |
65 | 2 |
Myasthenia gravis, Poor quality sleep, Decreased appetite, Vomiting, Infection, Pain in extremity, Nausea, Hypergeusia, Fatigue, Alopecia, Diarrhoea, Headache, Drug ineffective, Gait disturbance, |
||||
ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, |
||||
| 181 | 26933079 |
CA |
72 | 2 |
Malignant neoplasm progression, Fall, Contusion, Asthenia, Hospitalisation, Muscular weakness, Hypertension, Blood potassium decreased, Angioplasty, Malignant neoplasm progression, Gastric cancer, Headache, Migraine, Myalgia, Abdominal pain, Flatulence, Faeces discoloured, Nausea, Alopecia, Decreased appetite, Weight decreased, Breast discolouration, Insomnia, Pain in extremity, Off label use, Arthralgia, Diarrhoea, Abdominal pain upper, Off label use, Sinusitis, Eye infection, Anaemia, Pancreatic disorder, Vomiting, Nausea, Faeces discoloured, Abdominal pain upper, Polyp, Urinary tract infection, Fatigue, Diarrhoea, Abdominal distension, Stomach mass, Abdominal pain, Nausea, Vomiting, Diarrhoea, Fatigue, Polyp, Diarrhoea, Haemorrhoidal haemorrhage, Pain, Loss of personal independence in daily activities, Conjunctival laceration, Fall, Joint injury, Skin abrasion, Contusion, Pain, Fatigue, Pain, Nausea, Vomiting, Diarrhoea, Fall, Limb injury, Eye irritation, Walking aid user, Entropion, Asthenia, Fatigue, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANSOPRAZOLE, CLONAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CHOLESTYRAMINE, |
||||
| 182 | 26933151 |
CA |
43 | |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Ill-defined disorder, Impaired healing, Irritable bowel syndrome, Joint swelling, Lip dry, Live birth, Liver disorder, Pemphigus, Abdominal pain, Blister, Drug intolerance, Infusion related reaction, Injury, Liver injury, Lower limb fracture, Lung disorder, Malaise, Mobility decreased, Muscle injury, Musculoskeletal pain, Musculoskeletal stiffness, Nausea, Night sweats, Oedema, Osteoarthritis, Pain, Pericarditis, Peripheral swelling, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Adverse drug reaction, Adverse event, Headache, Helicobacter infection, Hypersensitivity, Hypertension, Hypoaesthesia, Infection, Folliculitis, Lower respiratory tract infection, Nasopharyngitis, Sinusitis, Contraindicated product administered, Exposure during pregnancy, Prescribed overdose, Maternal exposure during pregnancy, Pregnancy, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, |
||||
| 183 | 26933239 |
US |
1 | |
Gastrointestinal haemorrhage, Hypertensive crisis, Diarrhoea, Weight decreased, Decreased appetite, Pain, |
||||
NINTEDANIB, |
||||
| 184 | 26933278 |
GB |
1 | |
Swelling face, Decreased appetite, Malaise, |
||||
PIRFENIDONE, |
||||
| 185 | 26933359 |
EU |
75 | 1 |
Osteochondrosis, Chest pain, Back pain, Pain in extremity, Scoliosis, Diffuse idiopathic skeletal hyperostosis, Flank pain, Abdominal pain, Decreased appetite, Abdominal distension, Inflammatory marker increased, Gastrointestinal pain, Serum sickness, |
||||
DUPILUMAB, |
||||
| 186 | 26933697 |
JP |
67 | 2 |
Eosinophilic granulomatosis with polyangiitis, Malaise, Decreased appetite, Haematuria, Proteinuria, Eosinophilia, Renal necrosis, Inflammation, Granuloma, |
||||
SARILUMAB, SARILUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 187 | 26933708 |
US |
72 | 2 |
Off label use, Decreased appetite, Abdominal pain upper, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 188 | 26933746 |
83 | 1 | |
Ageusia, Decreased appetite, Fall, |
||||
LENALIDOMIDE, |
||||
| 189 | 26933876 |
CA |
1 | |
Decreased appetite, Urinary tract infection, Asthenia, |
||||
| 190 | 26933892 |
US |
63 | 2 |
Diarrhoea, Dehydration, Blood potassium decreased, Hepatic enzyme increased, Decreased appetite, Nausea, Asthenia, |
||||
SOTORASIB, |
||||
| 191 | 26933929 |
EU |
19 | 2 |
Crying, Anxiety, Pollakiuria, Decreased appetite, Affect lability, |
||||
TOPIRAMATE, |
||||
| 192 | 26938106 |
76 | 1 | |
Asthenia, Skin discolouration, Mobility decreased, Blood blister, Decreased appetite, Weight decreased, |
||||
NINTEDANIB, |
||||
| 193 | 26926666 |
US |
69 | 2 |
Decreased appetite, |
||||
PANCRELIPASE, |
||||
| 194 | 26926675 |
US |
2 | |
Muscle spasms, Diarrhoea, Asthenia, Gastrointestinal disorder, Decreased appetite, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 195 | 26926884 |
US |
2 | |
Decreased appetite, Asthenia, Fatigue, Diarrhoea, Drug ineffective, |
||||
ORFORGLIPRON, |
||||
| 196 | 26926951 |
2 | ||
Decreased appetite, Constipation, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 197 | 26927005 |
US |
81 | 2 |
Asthma, Blood glucose increased, Decreased appetite, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 198 | 26927054 |
US |
1 | |
Decreased appetite, Vomiting, Fatigue, |
||||
ORFORGLIPRON, ORFORGLIPRON, |
||||
| 199 | 26927137 |
US |
2 | |
Decreased appetite, |
||||
ORFORGLIPRON, |
||||
| 200 | 26927180 |
US |
2 | |
Muscle spasms, Decreased appetite, Retching, Diarrhoea, Dehydration, Weight decreased, Tinnitus, Nausea, |
||||
TEPROTUMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
